The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
5 Biggest Blockchain ETFs in 2025
next post
Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

Related Posts

Robotics Stocks: 10 Biggest Companies in 2025

September 16, 2025

Crypto Market Update: Trump Orders 401(k) Crypto Review,...

August 11, 2025

5 US Longevity and Anti-aging Stocks to Watch...

January 24, 2025

First Diamond Drilling Results at Ricciardo Deliver High-Grade...

July 5, 2024

Manganese Market Forecast: Top Trends for Manganese in...

January 23, 2026

Multiple Brines Horizons Intersected in Second Hole- Liberty...

February 13, 2024

Galan Lithium Limited: SUCCESSFUL DUE DILIGENCE COMPLETED –...

August 25, 2025

Increased Lion Participation in Brightstar Placement

September 13, 2024

Critical Metals Secures US$120 Million Loan LOI for...

June 20, 2025

Balkan Mining and Minerals Limited (ASX: BMM) –...

June 29, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,627)
    • Investing (5,287)
    • Politics (7,046)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved